PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway
Background/Aims: Although it has been widely accepted that protein arginine methyltransferase 1 (PRMT1) is a cancer-promoting gene in various cancers, the mechanism of PRMT1 in hepatocellular carcinoma (HCC) requires more exploration. This study aimed to investigate the role of PRMT1 in HCC growth a...
Main Authors: | Xiu-Ping Zhang, Ya-Bo Jiang, Cheng-Qian Zhong, Ning Ma, Er-Bin Zhang, Fan Zhang, Jing-Jing Li, Yue-Zhen Deng, Kang Wang, Dong Xie, Shu-Qun Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2018-06-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/490983 |
Similar Items
-
Cryptotanshinone chemosensitivity potentiation by TW-37 in human oral cancer cell lines by targeting STAT3–Mcl-1 signaling
by: In-Hyoung Yang, et al.
Published: (2020-08-01) -
An in-silico study examining the induction of apoptosis by Cryptotanshinone in metastatic melanoma cell lines
by: Radhika S. Saraf, et al.
Published: (2018-08-01) -
Protein arginine methyltransferases and hepatocellular carcinoma: A review
by: Yu Lei, et al.
Published: (2021-11-01) -
Discovery of a potent and dual-selective bisubstrate inhibitor for protein arginine methyltransferase 4/5
by: Ayad A. Al-Hamashi, et al.
Published: (2021-09-01) -
Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia
by: Zou Limin, et al.
Published: (2012-07-01)